Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-23T04:33:16.808Z Has data issue: false hasContentIssue false
  • English
  • Français

Major Depressive Disorder, Cognitive Symptoms, and Neuropsychological Performance among Ethnically Diverse HIV+ Men and Women

Published online by Cambridge University Press:  04 January 2013

Robert P. Fellows ,
Desiree A. Byrd  and
Susan Morgello
Robert P. Fellows*
Affiliation:
Department of Neurology, The Mount Sinai Medical Center, New York, New York
Desiree A. Byrd
Affiliation:
Department of Neurology, The Mount Sinai Medical Center, New York, New York
Susan Morgello
Affiliation:
Department of Neurology, The Mount Sinai Medical Center, New York, New York
*
Correspondence and reprint requests to: Robert P. Fellows, Department of Neurology, Box 1134 Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Major depressive disorder (MDD), cognitive symptoms, and mild cognitive deficits commonly occur in HIV-infected individuals, despite highly active antiretroviral therapies. In this study, we compared neuropsychological performance and cognitive symptoms of 191 HIV-infected participants. Results indicated that participants with a formal diagnosis of current MDD performed significantly worse than participants without MDD in all seven neuropsychological domains evaluated, with the largest effect sizes in information processing speed, learning, and memory. In addition, a brief assessment of cognitive symptoms, derived from a comprehensive neuromedical interview, correlated significantly with neurocognitive functioning. Participants with MDD reported more cognitive symptoms and showed greater neurocognitive deficits than participants without MDD. These findings indicate that HIV-infected adults with MDD have more cognitive symptoms and worse neuropsychological performance than HIV-infected individuals without MDD. The results of this study have important implications for the diagnosis of HIV-associated neurocognitive disorders (HAND). (JINS, 2013, 19, 1–10)

Keywords

DepressionCognitionCognitive complaintsNeuropsychological testsAcquired immunodeficiency syndromeMood disorders
Type
Research Articles
Information
Journal of the International Neuropsychological Society , Volume 19 , Issue 2 , February 2013 , pp. 216 - 225
Copyright
Copyright © The International Neuropsychological Society 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: American Psychiatric Association.Google Scholar
Antinori, A., Arendt, G., Becker, J.T., Brew, B.J., Byrd, D.A., Cherner, M., Wojna, V.E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799. doi:10.1212/01.WNL.0000287431.88658.8bCrossRefGoogle ScholarPubMed
Bassel, C., Rourke, S.B., Halman, M.H., Smith, M.L. (2002). Working memory performance predicts subjective cognitive complaints in HIV infection. Neuropsychology, 16(3), 400–410.CrossRefGoogle ScholarPubMed
Becker, J.T., Sanchez, J., Dew, M.A., Lopez, O.L., Dorst, S.K., Banks, G. (1997). Neuropsychological abnormalities among HIV-infected individuals in a community-based sample. Neuropsychology, 11(4), 592–601.CrossRefGoogle Scholar
Benedict, R.H. (1997). Brief Visuospatial Memory Test–Revised. Odessa, FL: Psychological Assessment Resources.Google Scholar
Benedict, R.H.B., Schretlen, D., Groninger, L., Brandt, J. (1998). Hopkins Verbal Learning Test-Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12(1), 43–55. doi:10.1076/clin.12.1.43.1726CrossRefGoogle Scholar
Bing, E.G., Burnam, M.A., Longshore, D., Fleishman, J.A., Sherbourne, C.D., London, A.S., Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the united states. Archives of General Psychiatry, 58(8), 721–728.CrossRefGoogle ScholarPubMed
Bix, B.C., Glosser, G., Holmes, W., Ballas, C., Meritz, M., Hutelmyer, C., Turner, J. (1995). Relationship between psychiatric disease and neuropsychological impairment in HIV seropositive individuals. Journal of the International Neuropsychological Society, 1(6), 581–588.CrossRefGoogle ScholarPubMed
Byrd, D.A., Fellows, R.P., Morgello, S., Franklin, D., Heaton, R.K., Deutsch, R., … CHARTER Group. (2011). Neurocognitive impact of substance use in HIV infection. Journal of Acquired Immune Deficiency Syndromes, 58(2), 154–162. doi:10.1097/QAI.0b013e318229ba41CrossRefGoogle ScholarPubMed
Carey, C.L., Woods, S.P., Gonzalez, R., Conover, E., Marcotte, T.D., Grant, I., … HNRC Group. (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26(3), 307–319. doi:10.1080/13803390490510031CrossRefGoogle ScholarPubMed
Carter, S.L., Rourke, S.B., Murji, S., Shore, D., Rourke, B.P. (2003). Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: A structural equation model analysis. Neuropsychology, 17(3), 410–419.CrossRefGoogle ScholarPubMed
Castellon, S.A., Hardy, D.J., Hinkin, C.H., Satz, P., Stenquist, P.K., van Gorp, W.G., Moore, L. (2006). Components of depression in HIV-1 infection: Their differential relationship to neurocognitive performance. Journal of Clinical zand Experimental Neuropsychology, 28(3), 420–437. doi:10.1080/13803390590935444CrossRefGoogle ScholarPubMed
Cherner, M., Bousman, C., Everall, I., Barron, D., Letendre, S., Vaida, F., … HNRC Group. (2010). Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: Preliminary findings. Journal of the International Neuropsychological Society, 16(5), 890–901. doi:10.1017/S1355617710000779CrossRefGoogle ScholarPubMed
Ciesla, J.A., Roberts, J.E. (2001). Meta-analysis of the relationship between HIV infection and risk for depressive disorders. The American Journal of Psychiatry, 158(5), 725–730.CrossRefGoogle ScholarPubMed
Cysique, L.A., Deutsch, R., Atkinson, J.H., Young, C., Marcotte, T.D., Dawson, L., … HNRC Group. (2007). Incident major depression does not affect neuropsychological functioning in HIV-infected men. Journal of the International Neuropsychological Society, 13(1), 1–11. doi:10.1017/S1355617707070026CrossRefGoogle Scholar
Devlin, K.N., Gongvatana, A., Clark, U.S., Chasman, J.D., Westbrook, M.L., Tashima, K.T., Cohen, R.A. (2012). Neurocognitive effects of HIV, hepatitis C, and substance use history. Journal of the International Neuropsychological Society: JINS, 18(1), 68–78. doi:10.1017/S1355617711001408CrossRefGoogle ScholarPubMed
Diehr, M.C., Cherner, M., Wolfson, T.J., Miller, S.W., Grant, I., Heaton, R.K., & HIV Neurobehavioral Research Center Group. (2003). The 50 and 100-item short forms of the paced auditory serial addition task (PASAT): Demographically corrected norms and comparisons with the full PASAT in normal and clinical samples. Journal of Clinical and Experimental Neuropsychology, 25(4), 571–585. doi:10.1076/jcen.25.4.571.13876CrossRefGoogle ScholarPubMed
Dunbar, N., Pemberton, L., Perdices, M., Brew, B.J. (1996). Clinical markers of the presence of dementia and neuropsychological impairment in HIV infection. Journal of Neuro-AIDS, 1(4), 31–48.CrossRefGoogle ScholarPubMed
Fellows, R.P., Byrd, D.A., Elliott, K., Robinson-Papp, J., Mindt, M.R., Morgello, S. (2012). Distal sensory polyneuropathy is associated with neuropsychological test performance among persons with HIV. Journal of the International Neuropsychological Society, 19, 1–10. doi:10.1017/S1355617712000707Google Scholar
Giunta, B., Ehrhart, J., Obregon, D.F., Lam, L., Le, L., Jin, J., Shytle, R.D. (2011). Antiretroviral medications disrupt microglial phagocytosis of beta-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders. Molecular Brain, 4(1), 23. doi:10.1186/1756-6606-4-23CrossRefGoogle ScholarPubMed
Gladsjo, J.A., Schuman, C.C., Evans, J.D., Peavy, G.M., Miller, S.W., Heaton, R.K. (1999). Norms for letter and category fluency: Demographic corrections for age, education, and ethnicity. Assessment, 6(2), 147–178.CrossRefGoogle ScholarPubMed
Goggin, K.J., Zisook, S., Heaton, R.K., Atkinson, J.H., Marshall, S., McCutchan, J.A., Grant, I. (1997). Neuropsychological performance of HIV-1 infected men with major depression. HNRC group. HIV neurobehavioral research center. Journal of the International Neuropsychological Society, 3(5), 457–464.CrossRefGoogle Scholar
Gonzalez, J.S., Batchelder, A.W., Psaros, C., Safren, S.A. (2011). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 58(2), 181–187. doi:10.1097/QAI.0b013e31822d490aCrossRefGoogle ScholarPubMed
Grant, I., Olshen, R.A., Atkinson, J.A., Heaton, R.K., Nelson, J., McCutchan, J.A., Weinrich, J.D. (1993). Depressed mood does not explain neuropsychological deficits in HIV-infected persons. Neuropsychology, 7(1), 53–61.CrossRefGoogle Scholar
Hasin, D.S., Trautman, K.D., Miele, G.M., Samet, S., Smith, M., Endicott, J. (1996). Psychiatric research interview for substance and mental disorders (PRISM): Reliability for substance abusers. The American Journal of Psychiatry, 153(9), 1195–1201.Google ScholarPubMed
Heaton, R., Grant, I., Matthews, C.G. (1991). Comprehensive norms for an expanded Halstead-Reitan Battery: Demographic corrections, research findings, and clinical applications. Odessa, FL: Psychological Assessment Resources.Google Scholar
Heaton, R.K., Clifford, D.B., Franklin, D.R. Jr., Woods, S.P., Ake, C., Vaida, F., … CHARTER Group. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology, 75(23), 2087–2096. doi:10.1212/WNL.0b013e318200d727CrossRefGoogle ScholarPubMed
Heaton, R.K., Franklin, D.R., Ellis, R.J., McCutchan, J.A., Letendre, S.L., Leblanc, S., … HNRC Group. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17(1), 3–16. doi:10.1007/s13365-010-0006-1CrossRefGoogle ScholarPubMed
Heaton, R.K., Grant, I., Butters, N., White, D.A., Kirson, D., Atkinson, J.H., Ellis, R.J. (1995). The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV neurobehavioral research center. Journal of the International Neuropsychological Society, 1(3), 231–251.CrossRefGoogle ScholarPubMed
Hesse, L.M., Greenblatt, D.J., von Moltke, L.L., Court, M.H. (2006). Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers. Journal of Clinical Pharmacology, 46(5), 567–576. doi:10.1177/0091270006286981CrossRefGoogle ScholarPubMed
Hinkin, C.H., van Gorp, W.G., Satz, P., Weisman, J.D., Thommes, J., Buckingham, S. (1992). Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. Journal of Clinical and Experimental Neuropsychology, 14(2), 289–297. doi:10.1080/01688639208402829CrossRefGoogle ScholarPubMed
Hogeland, G.W., Swindells, S., McNabb, J.C., Kashuba, A.D., Yee, G.C., Lindley, C.M. (2007). Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects. Clinical Pharmacology and Therapeutics, 81(1), 69–75. doi:10.1038/sj.clpt.6100027CrossRefGoogle ScholarPubMed
Ickovics, J.R., Hamburger, M.E., Vlahov, D., Schoenbaum, E.E., Schuman, P., Boland, R.J., … HIV Epidemiology Research Study Group. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV epidemiology research study. JAMA, 285(11), 1466–1474.CrossRefGoogle ScholarPubMed
Kalechstein, A.D., Hinkin, C.H., van Gorp, W.G., Castellon, S.A., Satz, P. (1998). Depression predicts procedural but not episodic memory in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology, 20(4), 529–535. doi:10.1076/jcen.20.4.529.1473CrossRefGoogle Scholar
Kongs, S.K., Thompson, L.L., Iverson, G.L., Heaton, R.K. (2000). WCST-64: Wisconsin Card Sorting Test-64 Card Version Professional Manual. Odessa, FL: Psychological Assessment Resources, Inc.Google Scholar
Lee, R.S., Hermens, D.F., Porter, M.A., Redoblado-Hodge, M.A. (2011). A meta-analysis of cognitive deficits in first-episode major depressive disorder. Journal of Affective Disorders, doi:10.1016/j.jad.2011.10.023Google ScholarPubMed
Leonard, B., Maes, M. (2012). Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neuroscience and Biobehavioral Reviews, 36(2), 764–785. doi:10.1016/j.neubiorev.2011.12.005CrossRefGoogle ScholarPubMed
Mapou, R.L., Law, W.A., Martin, A., Kampen, D., Salazar, A.M., Rundell, J.R. (1993). Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus. The Journal of Neuropsychiatry and Clinical Neurosciences, 5(1), 86–93.Google ScholarPubMed
Millikin, C.P., Rourke, S.B., Halman, M.H., Power, C. (2003). Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. Journal of Clinical and Experimental Neuropsychology, 25(2), 201–215. doi:10.1076/jcen.25.2.201.13644CrossRefGoogle Scholar
Moore, D.J., Arce, M., Moseley, S., McCutchan, J.A., Marquie-Beck, J., Franklin, D.R., … Charter Group and HNRC Group. (2011). Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. The Journal of Neuropsychiatry and Clinical Neurosciences, 23(3), 316–323. doi:10.1176/appi.neuropsych.23.3.316CrossRefGoogle ScholarPubMed
Morgello, S., Estanislao, L., Simpson, D., Geraci, A., DiRocco, A., Gerits, P., … Manhattan HIV Brain Bank. (2004). HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: The manhattan HIV brain bank. Archives of Neurology, 61(4), 546–551. doi:10.1001/archneur.61.4.546CrossRefGoogle ScholarPubMed
Morgello, S., Holzer, C.E. III, Ryan, E., Young, C., Naseer, M., Castellon, S.A., Singer, E.J. (2006). Interrater reliability of the psychiatric research interview for substance and mental disorders in an HIV-infected cohort: Experience of the national NeuroAIDS tissue consortium. International Journal of Methods in Psychiatric Research, 15(3), 131–138.CrossRefGoogle Scholar
Rabkin, J.G., Goetz, R.R., Remien, R.H., Williams, J.B., Todak, G., Gorman, J.M. (1997). Stability of mood despite HIV illness progression in a group of homosexual men. The American Journal of Psychiatry, 154(2), 231–238.Google Scholar
Richardson, M.A., Satz, P.F., Myers, H.F., Miller, E.N., Bing, E.G., Fawzy, F.I., Maj, M. (1999). Effects of depressed mood versus clinical depression on neuropsychological test performance among African American men impacted by HIV/AIDS. Journal of Clinical and Experimental Neuropsychology, 21(6), 769–783. doi:10.1076/jcen.21.6.769.860CrossRefGoogle ScholarPubMed
Rippeth, J.D., Heaton, R.K., Carey, C.L., Marcotte, T.D., Moore, D.J., Gonzalez, R., … HNRC Group. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society: JINS, 10(1), 1–14. doi:10.1017/S1355617704101021CrossRefGoogle ScholarPubMed
Robertson, K.R., Smurzynski, M., Parsons, T.D., Wu, K., Bosch, R.J., Wu, J., Ellis, R.J. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS (London, England), 21(14), 1915–1921. doi:10.1097/QAD.0b013e32828e4e27CrossRefGoogle ScholarPubMed
Robertson, K.R., Su, Z., Margolis, D.M., Krambrink, A., Havlir, D.V., Evans, S., … A5170 Study Team. (2010). Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology, 74(16), 1260–1266. doi:10.1212/WNL.0b013e3181d9ed09CrossRefGoogle Scholar
Rourke, S.B., Halman, M.H., Bassel, C. (1999). Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. Journal of Clinical and Experimental Neuropsychology, 21(6), 737–756. doi:10.1076/jcen.21.6.737.863CrossRefGoogle ScholarPubMed
Ryan, E.L., Baird, R., Mindt, M.R., Byrd, D., Monzones, J., Bank, S.M., & Manhattan HIV Brain Bank. (2005). Neuropsychological impairment in racial/ethnic minorities with HIV infection and low literacy levels: Effects of education and reading level in participant characterization. Journal of the International Neuropsychological Society, 11(7), 889–898.CrossRefGoogle ScholarPubMed
Saarto, T., Wiffen, P.J. (2007). Antidepressants for neuropathic pain. Cochrane Database Syst Rev, 4(4), CD005454. doi:10.1002/14651858.CD005454.pub2Google Scholar
Shimizu, S.M., Chow, D.C., Valcour, V., Masaki, K., Nakamoto, B., Kallianpur, K.J., Shikuma, C. (2011). The impact of depressive symptoms on neuropsychological performance tests in HIV-infected individuals: A study of the hawaii aging with HIV cohort. World Journal of AIDS, 1(4), 139–145. doi: 10.4236/wja.2011.14020CrossRefGoogle ScholarPubMed
Schroecksnadel, K., Sarcletti, M., Winkler, C., Mumelter, B., Weiss, G., Fuchs, D., Zangerle, R. (2008). Quality of life and immune activation in patients with HIV-infection. Brain, Behavior, and Immunity, 22(6), 881–889. doi:10.1016/j.bbi.2007.12.011CrossRefGoogle ScholarPubMed
Simioni, S., Cavassini, M., Annoni, J.M., Rimbault Abraham, A., Bourquin, I., Schiffer, V., Du Pasquier, R.A. (2010). Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS (London, England), 24(9), 1243–1250. doi:10.1097/QAD.0b013e3283354a7bCrossRefGoogle ScholarPubMed
Stern, Y., Marder, K., Bell, K., Chen, J., Dooneief, G., Goldstein, S., Williams, J. (1991). Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. neurologic and neuropsychological findings. Archives of General Psychiatry, 48(2), 131–138.CrossRefGoogle ScholarPubMed
Tekin, S., Cummings, J.L. (2002). Frontal-subcortical neuronal circuits and clinical neuropsychiatry: An update. Journal of Psychosomatic Research, 53(2), 647–654.CrossRefGoogle ScholarPubMed
Thames, A.D., Becker, B.W., Marcotte, T.D., Hines, L.J., Foley, J.M., Ramezani, A., Hinkin, C.H. (2011). Depression, cognition, and self-appraisal of functional abilities in HIV: An examination of subjective appraisal versus objective performance. The Clinical Neuropsychologist, 25(2), 224–243. doi:10.1080/13854046.2010.539577CrossRefGoogle ScholarPubMed
van der Lee, M.J., Blenke, A.A., Rongen, G.A., Verwey-van Wissen, C.P., Koopmans, P.P., Pharo, C., Burger, D.M. (2007). Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects. Antimicrobial Agents and Chemotherapy, 51(11), 4098–4104. doi:10.1128/AAC.01243-06CrossRefGoogle ScholarPubMed
van Gorp, W.G., Satz, P., Hinkin, C., Selnes, O., Miller, E.N., McArthur, J., Paz, D. (1991). Metacognition in HIV-1 seropositive asymptomatic individuals: Self-ratings versus objective neuropsychological performance. multicenter AIDS cohort study (MACS). Journal of Clinical and Experimental Neuropsychology, 13(5), 812–819. doi:10.1080/01688639108401091CrossRefGoogle ScholarPubMed
Verma, S., Estanislao, L., Mintz, L., Simpson, D. (2004). Controlling neuropathic pain in HIV. Current HIV/AIDS Reports, 1(3), 136–141.CrossRefGoogle ScholarPubMed
von Giesen, H.J., Backer, R., Hefter, H., Arendt, G. (2001). Depression does not influence basal ganglia-mediated psychomotor speed in HIV-1 infection. The Journal of Neuropsychiatry and Clinical Neurosciences, 13(1), 88–94.CrossRefGoogle Scholar
Warriner, E.M., Rourke, S.B., Rourke, B.P., Rubenstein, S., Millikin, C., Buchanan, L., Gough, K. (2010). Immune activation and neuropsychiatric symptoms in HIV infection. The Journal of Neuropsychiatry and Clinical Neurosciences, 22(3), 321–328. doi:10.1176/appi.neuropsych.22.3.321CrossRefGoogle ScholarPubMed
Wechsler, D. (1997). Wechsler Adult Intelligence Scale—Third edition: Administration and scoring manual. San Antonio, TX: Harcourt Brace.Google Scholar
Wilkinson, G. (1993). Wide Range Achievement Test (3rd ed.) administration manual. Wilmington, DE: Wide Range Inc.Google Scholar
Woods, S.P., Rippeth, J.D., Frol, A.B., Levy, J.K., Ryan, E., Soukup, V.M., Heaton, R.K. (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology, 26(6), 759–778. doi:10.1080/13803390490509565CrossRefGoogle ScholarPubMed
Zanjani, F., Saboe, K., Oslin, D. (2007). Age difference in rates of mental health/substance abuse and behavioral care in HIV-positive adults. AIDS Patient Care and STDs, 21(5), 347–355. doi:10.1089/apc.2007.0043CrossRefGoogle ScholarPubMed